These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7742034)

  • 1. A general model for the surface glycoproteins of HIV and other retroviruses.
    Gallaher WR; Ball JM; Garry RF; Martin-Amedee AM; Montelaro RC
    AIDS Res Hum Retroviruses; 1995 Feb; 11(2):191-202. PubMed ID: 7742034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservation of human immunodeficiency virus type 1 gp120 inner-domain sequences in lentivirus and type A and B retrovirus envelope surface glycoproteins.
    Hötzel I; Cheevers WP
    J Virol; 2001 Feb; 75(4):2014-8. PubMed ID: 11160703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins?
    Schulz TF; Jameson BA; Lopalco L; Siccardi AG; Weiss RA; Moore JP
    AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1571-80. PubMed ID: 1457203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservation of inner domain modules in the surface envelope glycoproteins of an ancient rabbit lentivirus and extant lentiviruses and betaretroviruses.
    Hötzel I
    Virology; 2008 Mar; 372(1):201-7. PubMed ID: 18037464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV/SIV glycoproteins: structure-function relationships.
    Douglas NW; Munro GH; Daniels RS
    J Mol Biol; 1997 Oct; 273(1):122-49. PubMed ID: 9367752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV glycosylation: what does it portend?
    Myers G; Lenroot R
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1459-60. PubMed ID: 1466982
    [No Abstract]   [Full Text] [Related]  

  • 7. A general model for the transmembrane proteins of HIV and other retroviruses.
    Gallaher WR; Ball JM; Garry RF; Griffin MC; Montelaro RC
    AIDS Res Hum Retroviruses; 1989 Aug; 5(4):431-40. PubMed ID: 2788443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional structure of the HTLV-II matrix protein and comparative analysis of matrix proteins from the different classes of pathogenic human retroviruses.
    Christensen AM; Massiah MA; Turner BG; Sundquist WI; Summers MF
    J Mol Biol; 1996 Dec; 264(5):1117-31. PubMed ID: 9000634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of synthetic peptides for the detection of antibodies against human immunodeficiency virus].
    Lottersberger J; Salvetti JL; Tonarelli G
    Rev Argent Microbiol; 2003; 35(3):149-55. PubMed ID: 14587377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer predictions of functional, topogenic, and antigenic domains in human immunodeficiency virus-2 envelope glycoprotein.
    Becker Y
    Virus Genes; 1992 Jan; 6(1):79-93. PubMed ID: 1549912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High degree of sensitivity of the simian immunodeficiency virus (SIVmac) envelope glycoprotein subunit association to amino acid changes in the glycoprotein 41 ectodomain.
    Marcon L; Sodroski J
    AIDS Res Hum Retroviruses; 1997 Apr; 13(6):441-7. PubMed ID: 9100985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GP120: target for neutralizing HIV-1 antibodies.
    Pantophlet R; Burton DR
    Annu Rev Immunol; 2006; 24():739-69. PubMed ID: 16551265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL; González SA
    Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL; Drummer HE; Wilson KA; Poumbourios P
    J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the HIV-1 gp120 V1/V2 domains in the induction of neutralizing antibodies].
    Granados-González V; Piedrahita LD; Martínez M; Genin C; Riffard S; Urcuqui-Inchima S
    Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):523-30. PubMed ID: 19409660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural biology of HIV.
    Turner BG; Summers MF
    J Mol Biol; 1999 Jan; 285(1):1-32. PubMed ID: 9878383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41.
    Caffrey M; Cai M; Kaufman J; Stahl SJ; Wingfield PT; Covell DG; Gronenborn AM; Clore GM
    EMBO J; 1998 Aug; 17(16):4572-84. PubMed ID: 9707417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short synthetic peptides derived from viral proteins compete with HIV gp120 for the binding to CD4 receptors.
    Chersi A; Pugliese O; Federico A; Viora M
    Viral Immunol; 2000; 13(4):547-54. PubMed ID: 11192301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes.
    Botarelli P; Houlden BA; Haigwood NL; Servis C; Montagna D; Abrignani S
    J Immunol; 1991 Nov; 147(9):3128-32. PubMed ID: 1717587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of the V3 loop of a Thailand HIV isolate.
    Gupta G; Anantharamaiah GM; Scott DR; Eldridge JH; Myers G
    J Biomol Struct Dyn; 1993 Oct; 11(2):345-66. PubMed ID: 8286061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.